ResMed Inc. Releases Transcript of FY 2025 Earnings Webcast

Reuters

2025/08/02

ResMed Inc. Releases Transcript of FY 2025 Earnings Webcast

ResMed Inc. recently released the transcript of its Q4 fiscal year 2025 earnings call, held on July 31, 2025. The event, webcast live from Sydney, was hosted by Salli Schwartz, ResMed's Chief Investor Relations Officer, and featured key executives, including CEO Michael Farrell and CFO Brett Sandercock. Analysts from various financial institutions, such as RBC Capital Markets, Goldman Sachs, and Morgan Stanley, participated in the conference call. During the call, ResMed's management discussed the company's ongoing focus on its core business of helping over 2.3 billion people worldwide with sleep apnea, insomnia, and respiratory insufficiency. The executives emphasized the company's commitment to healthcare delivery through its market-leading software. They also touched upon the potential resumption of the competitive bidding program by CMS, with the CEO stating, "Resmed has a long-standing track record of engaging constructively with the US government." The full transcript can be accessed through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief on August 02, 2025, and is solely responsible for the information contained therein.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2556884217"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2556884217\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2556884217?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-02 10:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2556884217","market":"us","top_or_hot":-1,"title":"ResMed Inc. Releases Transcript of FY 2025 Earnings Webcast","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      ResMed Inc. Releases Transcript of FY 2025 Earnings Webcast\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        ResMed Inc. recently released the transcript of its Q4 fiscal year 2025 earnings call, held on July 31, 2025. The event, webcast live from Sydney, was hosted by Salli Schwartz, ResMed's Chief Investor Relations Officer, and featured key executives, including CEO Michael Farrell and CFO Brett Sandercock. Analysts from various financial institutions, such as RBC Capital Markets, Goldman Sachs, and <a href=\"https://laohu8.com/S/MTK\">Morgan Stanley</a>, participated in the conference call. During the call, ResMed's management discussed the company's ongoing focus on its core business of helping over 2.3 billion people worldwide with sleep apnea, insomnia, and respiratory insufficiency. The executives emphasized the company's commitment to healthcare delivery through its market-leading software. They also touched upon the potential resumption of the competitive bidding program by CMS, with the CEO stating, \"Resmed has a long-standing track record of engaging constructively with the US government.\" The full transcript can be accessed through the link below.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief on August 02, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ResMed Inc. Releases Transcript of FY 2025 Earnings Webcast</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nResMed Inc. Releases Transcript of FY 2025 Earnings Webcast\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-08-02 10:28</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      ResMed Inc. Releases Transcript of FY 2025 Earnings Webcast\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        ResMed Inc. recently released the transcript of its Q4 fiscal year 2025 earnings call, held on July 31, 2025. The event, webcast live from Sydney, was hosted by Salli Schwartz, ResMed's Chief Investor Relations Officer, and featured key executives, including CEO Michael Farrell and CFO Brett Sandercock. Analysts from various financial institutions, such as RBC Capital Markets, Goldman Sachs, and <a href=\"https://laohu8.com/S/MTK\">Morgan Stanley</a>, participated in the conference call. During the call, ResMed's management discussed the company's ongoing focus on its core business of helping over 2.3 billion people worldwide with sleep apnea, insomnia, and respiratory insufficiency. The executives emphasized the company's commitment to healthcare delivery through its market-leading software. They also touched upon the potential resumption of the competitive bidding program by CMS, with the CEO stating, \"Resmed has a long-standing track record of engaging constructively with the US government.\" The full transcript can be accessed through the link below.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief on August 02, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RMD","symbol_name":"瑞思邁","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250802:nNDL3BDh5j:1","article_id":"2556884217","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2556884217","pubTimestamp":1754101733,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"ResMed Inc. recently released the transcript of its Q4 fiscal year 2025 earnings call, held on July 31, 2025. The event, webcast live from Sydney, was hosted by Salli Schwartz, ResMed's Chief Investor Relations Officer, and featured key executives, including CEO Michael Farrell and CFO Brett Sandercock. Analysts from various financial institutions, such as RBC Capital Markets, Goldman Sachs, and Morgan Stanley, participated in the conference call. During the call, ResMed's management discussed the company's ongoing focus on its core business of helping over 2.3 billion people worldwide with sleep apnea, insomnia, and respiratory insufficiency. The executives emphasized the company's commitment to healthcare delivery through its market-leading software. They also touched upon the potential resumption of the competitive bidding program by CMS, with the CEO stating, \"Resmed has a long-standing track record of engaging constructively with the US government.\" The full transcript can be acce","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"RMD":"瑞思迈"},"translate_title":"ResMed Inc.发布2025财年收益网络广播记录","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RMD":0.9},"content_text":"ResMed Inc. Releases Transcript of FY 2025 Earnings Webcast\n    \n\n        ResMed Inc. recently released the transcript of its Q4 fiscal year 2025 earnings call, held on July 31, 2025. The event, webcast live from Sydney, was hosted by Salli Schwartz, ResMed's Chief Investor Relations Officer, and featured key executives, including CEO Michael Farrell and CFO Brett Sandercock. Analysts from various financial institutions, such as RBC Capital Markets, Goldman Sachs, and Morgan Stanley, participated in the conference call. During the call, ResMed's management discussed the company's ongoing focus on its core business of helping over 2.3 billion people worldwide with sleep apnea, insomnia, and respiratory insufficiency. The executives emphasized the company's commitment to healthcare delivery through its market-leading software. They also touched upon the potential resumption of the competitive bidding program by CMS, with the CEO stating, \"Resmed has a long-standing track record of engaging constructively with the US government.\" The full transcript can be accessed through the link below.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief on August 02, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}